These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

448 related items for PubMed ID: 33260951

  • 1. Mechanisms of Colorectal Cancer Prevention by Aspirin-A Literature Review and Perspective on the Role of COX-Dependent and -Independent Pathways.
    Sankaranarayanan R, Kumar DR, Altinoz MA, Bhat GJ.
    Int J Mol Sci; 2020 Nov 27; 21(23):. PubMed ID: 33260951
    [Abstract] [Full Text] [Related]

  • 2. Salicylic acid metabolites and derivatives inhibit CDK activity: Novel insights into aspirin's chemopreventive effects against colorectal cancer.
    Dachineni R, Kumar DR, Callegari E, Kesharwani SS, Sankaranarayanan R, Seefeldt T, Tummala H, Bhat GJ.
    Int J Oncol; 2017 Dec 27; 51(6):1661-1673. PubMed ID: 29075787
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The Multifaceted Clinical Readouts of Platelet Inhibition by Low-Dose Aspirin.
    Patrono C.
    J Am Coll Cardiol; 2015 Jul 07; 66(1):74-85. PubMed ID: 26139061
    [Abstract] [Full Text] [Related]

  • 5. Chemoprevention of colorectal cancer: ready for routine use?
    Arber N, Levin B.
    Recent Results Cancer Res; 2005 Jul 07; 166():213-30. PubMed ID: 15648192
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Aspirin and the prevention of colorectal cancer.
    Ferrández A, Piazuelo E, Castells A.
    Best Pract Res Clin Gastroenterol; 2012 Apr 07; 26(2):185-95. PubMed ID: 22542156
    [Abstract] [Full Text] [Related]

  • 9. An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II.
    Moyad MA.
    Semin Urol Oncol; 2001 Nov 07; 19(4):306-16. PubMed ID: 11769882
    [Abstract] [Full Text] [Related]

  • 10. Aspirin as a chemopreventive agent for cutaneous melanoma: a literature review.
    Pulumati A, Algarin YA, Jaalouk D, Kim S, Latta S, Nouri K.
    Arch Dermatol Res; 2024 Jun 08; 316(7):367. PubMed ID: 38850411
    [Abstract] [Full Text] [Related]

  • 11. Evidence for colorectal cancer cell specificity of aspirin effects on NF kappa B signalling and apoptosis.
    Din FV, Dunlop MG, Stark LA.
    Br J Cancer; 2004 Jul 19; 91(2):381-8. PubMed ID: 15188000
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mediators of PGE2 synthesis and signalling downstream of COX-2 represent potential targets for the prevention/treatment of colorectal cancer.
    Chell S, Kaidi A, Williams AC, Paraskeva C.
    Biochim Biophys Acta; 2006 Aug 19; 1766(1):104-19. PubMed ID: 16859832
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cyclooxygenase-2 inhibitors in colorectal cancer.
    Stoehlmacher J, Lenz HJ.
    Semin Oncol; 2003 Jun 19; 30(3 Suppl 6):10-6. PubMed ID: 12802790
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.